Matrizyme
0 Reviews
About the Business
Matrizyme Pharma MZ-004 therapy for angioplasty in patients with CTO | Matrizyme Pharma Corporation has developed MZ-004, an innovative therapy to facilitate angioplasty in patients suffering from Chronic Total Occlusions. These 100% complete blockages of an artery represent a significant under-served market due to their complexity and high rate of treatment failure.
Contacts
Website
Call Us
+19057710333
65 West Beaver Creek Rd, Richmond Hill, ON L4B 1K4
Hours
Features
- Wheelchair-accessible parking lot
- Wheelchair-accessible entrance